Levels of advancement
II2 Laboratory assurance
The quality of laboratories (that conduct diagnostic testing or analysis for chemical residues, antimicrobial residues, toxins, or tests for, biological efficacy, etc.) as measured by the use of formal QA
1. No laboratories used by the public sector VS are using formal QA systems. 2. Some laboratories used by the public sector VS are using formal QA systems. 3. All laboratories used by the public sector VS are using formal QA systems. 4. All the laboratories used by the public sector VS and most or all private laboratories are using formal QA systems. 5. All the laboratories used by the public sector VS and most or all private laboratories are using formal QA programmes that meet OIE, ISO 17025, or equivalent QA standard guidelines.
Results Strengths : A Quality Manager has been recently recruited, filling a long‐standing vacancy Good collaboration with several reference labs abroad (e.g. VLA, IZSTE, OVI, BVI, BNL, IAEA Seiberdorf) Has met Quality assurance requirements, as part of the EU compliance audits National Pathology and Medical Laboratory are already accredited Weaknesses : Budgetary deficiencies especially for equipment, maintenance and personnel training While the CVL intends to seek accreditation by 2010, it is unlikely this can be attained without a significant improvement in filling vacancies, readjusting budget, and updating equipment Supporting documentation (documents or photos): PVS CVL updated 25 Jul 2008 version PVS presentation CVL 12 Aug 2008 Detailed finding during visit: Quality insurance: A quality manager was recruited 3‐4 months ago. A Laboratory Quality Manual (documented SOPs) is being used, and the goal is to obtain ISO 17025 accreditation by 2010 .
Priorities/Recommendations Short Term : Complete activities to seek laboratory accreditation in 2010 Medium / Long Term : Same as for II‐1